Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albanèse, J.
Right arrow Articles by Martin, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albanèse, J.
Right arrow Articles by Martin, C.
(Chest. 2004;126:534-539.)
© 2004 American College of Chest Physicians

Renal Effects of Norepinephrine in Septic and Nonseptic Patients*

Jacques Albanèse, MD; Marc Leone, MD; Franck Garnier, MD; Aurélie Bourgoin, MD; François Antonini, MD and Claude Martin, MD, FCCP

* From the Department of Anesthesiology and Intensive Care Medicine and Trauma Center, Marseilles University Hospital System, Marseilles School of Medicine, Marseilles, France.

Correspondence to: Claude Martin, MD, FCCP, Département d’Anesthésie et de Réanimation, CHU Nord, 13915 Marseille cedex 20, France; e-mail: claude.martin{at}ap-hm.fr

Objective: To assess the effects of a norepinephrine-induced vasoconstriction on renal function in septic and nonseptic patients.

Design: Open-label prospective study.

Setting: Medical-surgical ICU in an urban teaching hospital.

Patients: Fourteen patients with septic shock and 12 uninfected patients with head trauma (Glasgow coma score, < 8).

Interventions: Patients received norepinephrine infusion to increase systemic vascular resistance index (SVRI), and to raise mean arterial BP (MAP) to > 70 mm Hg in the septic group and cerebral perfusion pressure (CPP) to > 70 mm Hg in the head trauma group.

Measurements and main results: MAP and SVRI increased in both groups (p < 0.001), and CPP significantly increased in the head trauma group (p < 0.001). The cardiac index was not modified in either group. Norepinephrine infusion reestablished urine flow in 12 of the 14 septic patients (p < 0.001), with a decrease in serum creatinine levels (p < 0.001) and an increase in creatinine clearance rate (p < 0.001) after 24 h. Urine parameters were not affected in the head trauma group.

Conclusion: Within the limitation of the present study, norepinephrine administration induces a marked vasoconstriction in septic and nonseptic patients. Norepinephrine has positive effects on renal function in septic patients but has no significant effect on the same urinary parameters when administered to uninfected patients with normal renal function.

Key Words: kidney • norepinephrine • renal blood flow • septic • shock




This article has been cited by other articles:


Home page
ChestHome page
S. M. Hollenberg
Vasopressor Support in Septic Shock
Chest, November 1, 2007; 132(5): 1678 - 1687.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.